welcome
Reuters

Reuters

Health

Health

Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs

Reuters
Summary
Nutrition label

77% Informative

Telehealth companies are embracing weight-loss drugs and building offerings around them.

WeightWatchers filed for bankruptcy this week citing vastly increased use of the new blockbuster medicines.

Federal regulators crack down on cheaper versions of Novo Nordisk's Wegovy and Eli Lilly's Zepbound that have become a big part of the companies' sales.

The companies' success may ultimately depend on partnering with name brand drugmakers.

(Reporting by Amina Niasse and Nicholas P. Brown in New York ; Additional reporting by Dietrich Knauch in New York ; Editing by Peter Henderson , Caroline Humer and Bill Berkrot ).

VR Score

85

Informative language

90

Neutral language

55

Article tone

semi-formal

Language

English

Language complexity

52

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links